Business Blockbuster - Helpng business to be more visible on Google
The Times Australia

Notice to Long-term Integra Lifesciences Holdings Corporation (IART) Shareholders: Grabar Law Investigates Claims on Your Behalf

Philadelphia, Pennsylvania - Newsfile Corp. - March 24, 2025 - Grabar Law Office is investigating whether the Board of Directors of Integra LifeSciences Holdings Corp. (NASDAQ: IART) breached their fiduciary duties owed to the Company.



Current Integra LifeSciences Holdings Corp. (NASDAQ: IART) shareholders who have held the stock since on or before March 11, 2019, can seek corporate reforms, the return of funds spent defending litigation back to the company, and a court approved incentive award, at no cost to them. Learn more or join at: https://grabarlaw.com/the-latest/intrga-lifesciences-shareholder-investigation/. Contact Joshua H. Grabar at jgrabar@grabarlaw.com, or call 267-507-6085.

WHY: An underlying securities fraud class action complaint alleges that Integra, via certain of his officers and directors, repeatedly touted that it was on track to grow SurgiMend's market by obtaining FDA approval for use in post-mastectomy reconstruction, yet on May 23, 2023, the Company was forced to announce a "recall" of all products manufactured at its Boston Facility between March 1, 2018 and May 22, 2023. Integra LifeSciences explained that it had determined that the Boston Facility deviated from good manufacturing practices in testing for bacterial endotoxin and allowed the release of products with unsafe levels of endotoxins. As a result of the recall and manufacturing shutdown, the Company revised its guidance for the second quarter of 2023, lowering its revenue expectations by and disclosed that it expected to take a $22 million impairment due to the inventory write-off.

WHAT TO DO NOW: Current Integra LifeSciences shareholders who have held Integra LifeSciences shares since on or before March 11, 2019, can seek corporate reforms, the return of funds spent defending litigation back to the company, and a court approved incentive award, at no cost to them.

If you would like to learn more about this matter, you are encouraged to visit https://grabarlaw.com/the-latest/intrga-lifesciences-shareholder-investigation/, contact Joshua H. Grabar at jgrabar@grabarlaw.com, or call us at 267-507-6085. $IART #IntegraLifeSciences

Attorney Advertising Disclaimer

Contact:
Joshua H. Grabar, Esq.
Grabar Law Office
One Liberty Place
1650 Market Street, Suite 3600
Philadelphia, PA 19103
Tel: 267-507-6085
Email: jgrabar@grabarlaw.com

The issuer is solely responsible for the content of this announcement.

Times Magazine

What is a passkey — and should you use one instead of a password?

Websites increasingly invite users to create a passkey. The unfamiliar name describes a simpler wa...

A quality cut to bills for Beaufort butcher

Victorians are increasingly turning to Easy Electric SEC to better understand their home energy op...

Mentoring - Raising a child is more than providing for one

Food, shelter, safety and schooling are essential. But the guidance children receive about how to ...

Technology

What is a passkey — and should you …

Websites increasingly invite users to create a passkey. The unfamiliar name describes a simpler wa...

Local News

Brisbane Airport’s second runway ha…

Two parallel runways give Queensland’s main airport more capacity and greater flexibility. For tra...

Culture

Health is connected. Your data should be too.

Why health data matters most when it helps people make better decisions in everyday life. The healt...

Travel

Travel Trends 2027: Why Asia-Pacific Travelle…

Travellers from Australia and Southeast Asia are spending more on what they do and less on where t...

The Times Features

Choosing the Right Childcare for Your Family

Selecting the appropriate childcare for your family represents a significant decision, impacting bot...

Health is connected. Your data should be too.

Why health data matters most when it helps people make better decisions in everyday life. The healt...

Why Construction Heavyweights Are Backing This Brisbane…

Backed by Antler, McNab Group, Hutchinson Builders, KPAT and private investors, Casu is building a...